The company launched the BD FACSseq flow cytometer and BD Precise Assays for high-throughput single-cell gene-expression analysis studies at the ASHG annual meeting.
The company reported preliminary Q3 revenue growth of between 52 percent and 68 percent, and raised its revenue guidance for full-year 2015.
The single-cell genomics center at the Monash Health Translation Precinct near Melbourne will be the first of its kind in Australia.
The center expands the collaboration between the two organizations at the Jackson Laboratory for Genomic Medicine.
BD plans to pair Cellular Research's highly multiplexed gene expression technology with its flow cytometry platforms.
The company also significantly reduced its full-year 2015 revenue guidance, and noted that it has initiated organizational changes to address underlying issues.
Qiagen believes it has gained access to a relatively simple and inexpensive technology to bolster its offerings in the growing single-cell molecular biology market.
Both groups are making their detailed protocols available to researchers online.
Single-molecule biology and single-cell genomics are poised to enable precision medicine, writes Harvard's X. Sunney Xie in JAMA.
The firm reported revenues of $26.7 million, up 4 percent from $25.7 million in the year-ago period, but short of the Wall Street estimate of $30.7 million.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.